Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Merck & Co., Inc. is a health care company ... animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

Premier products in Merck’s portfolio include Keytruda ... Overall MRK ranks 1st on our list of the most promising cancer stocks according to hedge funds. While we acknowledge the potential ...

This year, Merck also ranked No. 1 in its industry on CNBC and JUST Capital's list of America's Most JUST Companies and ... technological advances, new products and patents attained by competitors; ...